London Stock Exchange · Healthcare
Invest in Faron Pharmaceuticals Oy stock from India
Indian and foreign residents can buy Faron Pharmaceuticals Oy (FARN) shares directly through Paasa.
By Paasa · Updated
Faron Pharmaceuticals Oy at a glance
- Price
- £0.36-£0.02 (5.16%)
- Market cap
- £71.34M
- Day range
- £0.36 – £0.38
- P/E
- -3.30
- Dividend yield
- None
- Volume
- 20.81K
- 1 month
- -9.90%
- 6 months
- -18.09%
- YTD
- -79.98%
- 1 year
- -79.98%
- 5 years
- -88.43%
Faron Pharmaceuticals Oy statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €0.0 | €0.0 | €0.0 | €0.0 | €0.0 |
| Gross profit | −€325.9K | €0.0 | €0.0 | €0.0 | €0.0 |
| Operating income | −€20.3M | −€18.7K | −€28.6M | −€27.4M | −€21.1M |
| Net income | −€27.2M | −€25.9K | −€30.9M | −€28.7M | −€21.2M |
| Earnings per share | −€0.25 | −€0.00 | −€0.34 | −€0.38 | −€0.29 |
| EBITDA | −€19.9M | −€18.5K | −€28.4M | −€27.1M | −€21.0M |
| Total assets | €17.2M | €12.5M | €10.2M | €11.3M | €13.2M |
| Total debt | €24.7M | €12.1M | €13.1M | €13.3M | €3.5M |
| Cash and short-term investments | €12.3M | €9.5M | €6.9M | €7.0M | €6.9M |
| Shareholders' equity | −€18.5M | −€9.8M | −€15.2M | −€11.5M | €2.9M |
| Operating cash flow | −€17.9M | −€23.0M | −€23.8M | −€23.0M | −€22.2M |
| Free cash flow | −€18.1M | −€23.2M | −€23.9M | −€23.4M | −€22.7M |
| Capital expenditure | −€222.0K | −€226.0K | −€123.0K | −€385.0K | −€474.0K |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Avacta | AVCT.L | £0.72 | £337.25M |
| PureTech Health | PRTC.L | £1.15 | £280.90M |
| Beximco Pharmaceuticals | BXP.L | £0.51 | £228.99M |
| Scancell | SCLP.L | £0.09 | £96.78M |
| Bioventix | BVXP.L | £16.78 | £87.67M |
| 4basebio | 4BB.L | £5.50 | £85.21M |
| Ondine Biomedical | OBI.L | £0.10 | £50.54M |
| Sareum | SAR.L | £0.31 | £42.33M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Faron Pharmaceuticals Oy from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to GBP when you buy.
Step 3
Search FARN and buy
Find Faron Pharmaceuticals Oy by name or by its ticker, FARN, and place your order.
Why invest in Faron Pharmaceuticals Oy from India
What Faron Pharmaceuticals Oy does
Established in Turku, Finland, in 2003, Faron Pharmaceuticals Oy operates as a clinical-stage biotechnology firm dedicated to the discovery and advancement of novel pharmaceutical solutions. The company's core focus lies in harnessing immune modulation to develop proprietary drug candidates addressing significant unmet medical needs. Faron Pharmaceuticals Oy operates in the Biotechnology industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Faron Pharmaceuticals Oy stock from India?
Yes. Indian residents and NRIs can buy Faron Pharmaceuticals Oy (FARN) shares directly through Paasa. Faron Pharmaceuticals Oy is listed on the London Stock Exchange, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are Faron Pharmaceuticals Oy dividends taxed for Indian investors?
Faron Pharmaceuticals Oy trades on the London Stock Exchange but is domiciled in Finland, so any withholding on its dividends follows that country's rules rather than those of the UK. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Faron Pharmaceuticals Oy shares?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the GBP/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.
Is there stamp duty when I buy Faron Pharmaceuticals Oy shares?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.